L-ephedrine-induced neuro degeneration in the parietal cortex and thalamus of the rat is dependent on hyperthermia and can be altered by the process of in vivo brain microdialysis

被引:8
作者
Bowyer, JF [1 ]
Hopkins, KJ [1 ]
Jakab, R [1 ]
Ferguson, SA [1 ]
机构
[1] US FDA, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
关键词
neurotoxicity; ephedrine; amphetamine; cortex; thalamus; microdialysis;
D O I
10.1016/S0378-4274(01)00440-4
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Multiple doses of the dietary supplement L-ephedrine can cause severe hyperthermia, and modest dopamine depletions in the rat brain. Since D-amphetamine treatment can result in neurodegeneration, the potential of L-ephedrine to produce similar types of degeneration was investigated. Adult male rats, some implanted in the caudate/putamen (CPu) for microdialysis, were given four doses of 25 mg/kg L-ephedrine or 5 mg/kg D-amphetamine (2 h between doses) at an ambient temperature of 23 degreesC. L-ephedrine-induced degeneration in the forebrain was dependent on the degree of hyperthermia. Layer IV of the parietal cortex was the most Sensitive to L-ephedrine treatment with peak body temperatures of at most 40.0 degreesC necessary to produce degeneration. Extensive neurodegeneration in the parietal cortex after L-ephedrine treatment was as pronounced as that previously described for D-amphetamine treatment and also occurred in the intralaminar, ventromedial and ventrolateral thalamic nuclei in rats with severe hyperthermia (peak body temperatures>41.0 degreesC). The neurodegeneration induced by L-ephedrine may have resulted in part from excitotoxic mechanisms involving the indirect pathways of the basal ganglia and related areas. No differences were observed between microdialysis and non-implanted rats with respect to degree of tyrosine hydroxylase (TH) loss in the CPu after either D-amphetamine or L-ephedrine treatment. However, neuro degeneration resulting from D-amphetamine and L-ephedrine was reduced in the microdialysis animals in the hemisphere ipsilateral to the probe, which raises concerns when using the technique of in vivo microdialysis to evaluate neurodegeneration. The results of this study, in conjunction with human clinical evaluation of ephedrine neurotoxicity, indicate that regionally specific damage may occur in the cortex of some humans exposed to ephedrine in the absence of stroke or hemorrhage. (C) 2001 Published by Elsevier Science Ireland Ltd.
引用
收藏
页码:151 / 166
页数:16
相关论文
共 56 条
  • [1] [Anonymous], [No title captured]
  • [2] AXELROD J, 1953, J PHARMACOL EXP THER, V109, P62
  • [3] Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research
    Bartzokis, G
    Beckson, M
    Lu, PH
    Edwards, N
    Rapoport, R
    Wiseman, E
    Bridge, P
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 2000, 98 (02) : 93 - 102
  • [4] Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise
    Bell, DG
    Jacobs, I
    Zamecnik, J
    [J]. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 1998, 77 (05) : 427 - 433
  • [5] Bell DG, 1999, AVIAT SPACE ENVIR MD, V70, P583
  • [6] BOWYER JF, 1994, J PHARMACOL EXP THER, V268, P1571
  • [7] Neuronal degeneration in rat forebrain resulting from D-amphetamine-induced convulsions is dependent on seizure severity and age
    Bowyer, JF
    Peterson, SL
    Rountree, RL
    Tor-Agbidye, J
    Wang, GJ
    [J]. BRAIN RESEARCH, 1998, 809 (01) : 77 - 90
  • [8] An evaluation of I-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate
    Bowyer, JF
    Newport, GD
    Slikker, W
    Gough, B
    Ferguson, SA
    Tor-Agbidye, J
    [J]. TOXICOLOGICAL SCIENCES, 2000, 55 (01) : 133 - 142
  • [9] STROKE ASSOCIATED WITH EPHEDRINE USE
    BRUNO, A
    NOLTE, KB
    CHAPIN, J
    [J]. NEUROLOGY, 1993, 43 (07) : 1313 - 1316
  • [10] Burrows KB, 1997, SYNAPSE, V27, P133, DOI 10.1002/(SICI)1098-2396(199710)27:2<133::AID-SYN4>3.3.CO